Top life sciences companies trust Domino for data science innovation (30s)
Domino for Life Sciences
The platform for data-driven drug development
Robust analytics and AI solutions for the entire pharma value chain
In a rapidly evolving data landscape, Domino’s future-proof platform empowers life sciences companies to enhance collaboration, streamline workflows, and support the entire pharmaceutical lifecycle, from early research and discovery to clinical analytics and post-launch activities.
Our mission is to bridge the gap between data science, IT, and business teams with a single, unified platform. Power faster time to insights, reduce costs, and accelerate time-to-market for new therapies while maintaining the highest standards for data integrity and compliance.
- Bioinformatics
- Discovery
- Clinical Trials / SCE
- Commercial / Operations
- Real-world evidence
Turn data into insights faster with streamlined bioinformatics workflows
Utilize state-of-the-art data science technologies like machine learning operations (MLOps) and Nextflow to streamline DNA/RNA sequencing and proteomics workflows. Accelerate research on vaccines, cancer prevention, cell mutation predictions, personalized medicine, and drug discovery.
Top 10 global pharmaceutical company
Learn how this customer used Domino MLOps to analyze data from over 10,000 tumors to identify new classes of drugs and the discovery of a specific chromosome that can impact immunity to cancer cells.
Accelerate the discovery process and make informed decisions in drug development
Integrate siloed data sources and apply the use of machine learning (ML) to discover patterns acting as a catalyst for research and accelerating the discovery process. Domino for Life Sciences reduces the time it takes to identify new targets, design proteins, and generate new molecules.
See how Lilly is driving value with ML strategies across their business, including using data science and ML to understand single-cell trajectories for different disease states, powering the discovery of new therapies.
Modernize clinical analytics with a unified, compliant statistical computing environment (SCE)
Learn how GSK accelerated clinical reporting and improved audit readiness by unifying teams on the Domino SCE for Life Sciences. With flexible, scalable, and compliant infrastructure, GSK now supports both exploratory and regulatory work on a single platform.
The Domino SCE for Life Sciences is a centrally managed, audit-ready platform that unifies GxP and non-GxP workflows in a single environment. It offers advanced flexibility, scalability, and governance to support a range of users including statisticians, programmers, and data scientists. With automation, flexible tooling, and built-in compliance, the platform ensures accuracy, reproducibility, and regulatory readiness for modern clinical analytics.
Increase productivity, reduce costs, and enhance patient experiences
Domino allows Bayer’s sales teams to access more detailed information about customers’ specific needs to deliver personalized product recommendations for each customer. This customized approach improves customer success and satisfaction.
Leverage data science and train ML models to drive value across operations, sales, and marketing. Achieve more accurate demand forecasting and predictive maintenance, or launch personalized omnichannel marketing campaigns and construct unique patient engagement programs.
Scale real-world evidence with a compliant, flexible platform
Life sciences teams accelerate real-world evidence and reduce time to submission with Domino. A flexible, compliant platform helps unify teams, reuse analytics, and deliver insights that inform trials, payer strategy, and regulatory decisions.
Top 20 pharmaceutical company
A top life sciences organization used Domino to uncover drivers of variable treatment response using real-world data. By connecting cross-functional datasets, they enabled more equitable access, improved model performance, and accelerated clinical decisions.
On-demand demo: Unlock real-world evidence at scale
Pharmaceutical companies are under pressure to deliver more transparent, timely, and traceable real-world evidence. Domino helps teams generate RWE faster by unifying infrastructure, analytics, and governance in a single platform so you can deliver reusable, interactive insights that meet the highest regulatory standards. Watch the demo to see how to:
- Work with diverse real-world data sources from a single, governed platform
- Build and deploy predictive models to support causal inference, cost prediction, and patient stratification
- Deliver interactive dashboards and apps for clinical and business users to explore insights
- Ensure reproducibility and audit readiness with built-in versioning, traceability, and compliance
- Scale from one-off studies to enterprise-wide pipelines for real-time evidence generation
Achieve real value with Domino for Life Sciences
Domino has made it easier for users across the global enterprise, using different tools and with varied backgrounds and skill sets, to work with each other, leverage past work, and collaborate quickly.
Naveen Singla
Former Data Science Center of Excellence Lead, Bayer
The reason we chose Domino was because of its flexibility. We wanted a single platform for both exploratory and GxP work.
Eileen Ching
Senior Director, Technical Capability Delivery R&D Biostatistics, GSK
With the help of Domino’s platform, BMS’s translational bioinformatics team can now successfully test tens of thousands of hypotheses with complete reproducibility to accelerate their fight against cancer.
Pharma Tech Outlook
“Domino Data Lab: Imbuing innovation in model-driven businesses”
Domino for Life Sciences is trusted by 10 of the top 20 global pharmaceutical companies
